首页> 外文期刊>Journal of the American Chemical Society >Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers
【24h】

Site-Directed Fragment-Based Screening for the Discovery of Protein-Protein Interaction Stabilizers

机译:基于定点片段的筛选,用于发现蛋白质-蛋白质相互作用稳定剂

获取原文
获取原文并翻译 | 示例
       

摘要

Modulation of protein-protein interactions (PPIs) by small molecules has emerged as a valuable approach in drug discovery. Compared to direct inhibition, PPI stabilization is vastly underexplored but has strong advantages, including the ability to gain selectivity by targeting an interface formed only upon association of proteins. Here, we present the application of a site-directed screening technique based on disulfide trapping (tethering) to select for fragments that enhance the affinity between protein partners. We target the phosphorylation-dependent interaction between the hub protein 14-3-3 sigma and a peptide derived from Estrogen Receptor alpha (ER alpha), an important breast cancer target that is negatively regulated by 14-3-3 sigma. We identify orthosteric stabilizers that increase 14-3-3/ER alpha affinity up to 40-fold and propose the mechanism of stabilization based on X-ray crystal structures. These fragments already display partial selectivity toward ER alpha-like motifs over other representative 14-3-3 clients. This first of its kind study illustrates the potential of the tethering approach to overcome the hurdles in systematic PPI stabilizer discovery.
机译:小分子对蛋白质-蛋白质相互作用(PPI)的调节已成为药物发现中的一种有价值的方法。与直接抑制相比,PPI稳定作用尚未得到充分开发,但具有强大的优势,包括通过靶向仅在蛋白质缔合时形成的界面来获得选择性的能力。在这里,我们介绍基于二硫键捕获(束缚)的定点筛选技术的应用,以选择能增强蛋白质伴侣之间亲和力的片段。我们的目标是枢纽蛋白14-3-3 sigma和源自雌激素受体alpha(ER alpha)的肽之间的磷酸化依赖性相互作用,这是一个重要的乳腺癌靶标,受14-3-3 sigma负调控。我们确定了增加14-3-3 / ERα亲和力至40倍的正构稳定剂,并提出了基于X射线晶体结构的稳定机制。这些片段已经比其他代表性的14-3-3客户显示出对ER alpha样基序的部分选择性。这是同类研究中的第一个,它说明了使用网络共享方法克服系统性PPI稳定剂发现障碍的潜力。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2019年第8期|3524-3531|共8页
  • 作者单位

    Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, NL-5600 MB Eindhoven, Netherlands|Eindhoven Univ Technol, ICMS, NL-5600 MB Eindhoven, Netherlands;

    Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA|Univ Calif San Francisco, SMDC, San Francisco, CA 94143 USA;

    Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, NL-5600 MB Eindhoven, Netherlands|Eindhoven Univ Technol, ICMS, NL-5600 MB Eindhoven, Netherlands;

    Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, NL-5600 MB Eindhoven, Netherlands|Eindhoven Univ Technol, ICMS, NL-5600 MB Eindhoven, Netherlands;

    Novartis Inst Biomed Res, Chem Biol & Therapeut, CH-4056 Basel, Switzerland;

    Novartis Inst Biomed Res, Chem Biol & Therapeut, CH-4056 Basel, Switzerland;

    Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, NL-5600 MB Eindhoven, Netherlands|Eindhoven Univ Technol, ICMS, NL-5600 MB Eindhoven, Netherlands;

    Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA|Univ Calif San Francisco, SMDC, San Francisco, CA 94143 USA;

    Eindhoven Univ Technol, Dept Biomed Engn, Lab Chem Biol, NL-5600 MB Eindhoven, Netherlands|Eindhoven Univ Technol, ICMS, NL-5600 MB Eindhoven, Netherlands|Univ Duisburg Essen, Dept Chem, D-47057 Essen, Germany;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-18 04:12:49

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号